c.
Based in Ann Arbor, MI, Assay Designs develops and manufactures
immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and
extracts used for life sciences research. The company markets these
products under the Assay Designs and Stressgen(R) brand names. Researchers
use the company's products to detect and quantify molecules that are
important in inflammation, cell signaling, and cellular stress. New assay
platforms include MultiBead(TM) bead-based multiplex immunoassay kits and
ImmunoSet(TM) ELISA development reagents.
About Anbova Corporation
Abnova is a bio-tool proteomic company specializing in automated, high
throughput protein expression and antibody production. The system Abnova
has developed is a unique combination of world-class technologies and
management experience of the IT industry in Taiwan. The company's goal is
to vastly expand the scope and availability of bio-tool reagents. As such,
it is a taking a genome-wide approach to the production of human
recombinant protein and antibody, and is developing a portfolio of
integrated and systemized applications including immuno- and
multiplex-assays covering protein families that are essential to the drug
discovery and diagnostic industries.
'/>"/>SOURCE Assay Designs, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer2.
The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays3.
Novel Mass Spectrometry-based Assay Reveals Degradation and Low Levels of Bioactive B-type Natriuretic Peptide (BNP) in Patients with Heart Failure4.
Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays5.
CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit6.
MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting7.
Monogram and Dana-Farber Cancer Institute Initiate Evaluation of HERmark(TM) Breast Cancer Assay in Metastatic Breast Cancer8.
ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 119.
Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options10.
Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)11.
Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use of HemosIL(R) D-Dimer Assay